Post by Possibleidiot01on Sep 05, 2024 5:22pm
277 Views
Post# 36210692
addition to latest Atrium takeover report
addition to latest Atrium takeover reporthttps://mcusercontent.com/4bc421505c66d079778a0d0be/files/c84f1943-b069-7c62-f72d-87f54a469d3b/20240905_Atrium_Takeouts_Part_3.02.pdf
Small-Cap Takeouts
Thematic Research
4September 5, 2024
Crescita Therapeutics Inc. (CTX:TSX)
Crescita is a Canadian commercial dermatology company focused on growth and innovation,
offering a range of science-based skincare products, both non-prescription and prescription. The
Company owns proprietary transdermal delivery platforms and specializes in dermocosmetic
products, which address specific skin concerns through clinically proven active ingredients. CTX’s
product portfolio serves both the aesthetic skincare and medical aesthetics markets in Canada, with
a presence in international markets like Malaysia and South Korea. CTX’s operations include in-
house R&D and manufacturing capabilities, providing turnkey solutions for product development
and launch from their facility in Laval, Qubec. CTX has secured multiple new contracts in 2024,
including a $10M, four-year manufacturing agreement with its largest client and a manufacturing
deal with a new dermatology client for up to $6M per year. CTX has $9M in cash with only $1M in
leases and a market cap of $12M.